Literature DB >> 10881344

Theodore Woodward Award. Pathogenesis of biochemical abnormalities in protoporphyria.

J R Bloomer1, M B Poh-Fitzpatrick.   

Abstract

In summary, FC gene mutations in patients with protoporphyric liver disease typically cause major structural alterations in the FC protein. However, the gene mutations by themselves do not satisfactorily account for the severe phenotype, as the same mutations are found in asymptomatic family members, and similar mutations are found in patients who do not develop liver disease. Thus there may be unidentified factors in the FC gene locus, or factors outside the locus, which are also important in determining the degree of protoporphyrin accumulation that occurs in an individual patient, hence, the potential for developing significant liver disease. Further studies are needed to clarify this possibility and identify those factors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881344      PMCID: PMC2194363     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  34 in total

1.  Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia.

Authors:  I A MAGNUS; A JARRETT; T A PRANKERD; C RIMINGTON
Journal:  Lancet       Date:  1961-08-26       Impact factor: 79.321

2.  Molecular characterization of a ferrochelatase gene defect causing anomalous RNA splicing in erythropoietic protoporphyria.

Authors:  R P Sarkany; D M Whitcombe; T M Cox
Journal:  J Invest Dermatol       Date:  1994-04       Impact factor: 8.551

3.  Structure of the human ferrochelatase gene. Exon/intron gene organization and location of the gene to chromosome 18.

Authors:  S Taketani; J Inazawa; Y Nakahashi; T Abe; R Tokunaga
Journal:  Eur J Biochem       Date:  1992-04-01

4.  A novel mutation in erythropoietic protoporphyria: an aberrant ferrochelatase mRNA caused by exon skipping during RNA splicing.

Authors:  X Wang; M Poh-Fitzpatrick; D Carriero; L Ostasiewicz; T Chen; S Taketani; S Piomelli
Journal:  Biochim Biophys Acta       Date:  1993-04-30

5.  Human erythropoietic protoporphyria: identification of a mutation at the splice donor site of intron 7 causing exon 7 skipping of the ferrochelatase gene.

Authors:  Y Nakahashi; H Miyazaki; Y Kadota; Y Naitoh; K Inoue; M Yamamoto; N Hayashi; S Taketani
Journal:  Hum Mol Genet       Date:  1993-07       Impact factor: 6.150

6.  The functional size of ferrochelatase determined in situ by radiation inactivation.

Authors:  J G Straka; J R Bloomer; E S Kempner
Journal:  J Biol Chem       Date:  1991-12-25       Impact factor: 5.157

7.  A molecular defect in human protoporphyria.

Authors:  D A Brenner; J M Didier; F Frasier; S R Christensen; G A Evans; H A Dailey
Journal:  Am J Hum Genet       Date:  1992-06       Impact factor: 11.025

8.  Screening for ferrochelatase mutations: molecular heterogeneity of erythropoietic protoporphyria.

Authors:  X Wang; M Poh-Fitzpatrick; S Taketani; T Chen; S Piomelli
Journal:  Biochim Biophys Acta       Date:  1994-01-11

9.  Recessive inheritance of erythropoietic protoporphyria with liver failure.

Authors:  R P Sarkany; G J Alexander; T M Cox
Journal:  Lancet       Date:  1994-06-04       Impact factor: 79.321

10.  Molecular defect in human erythropoietic protoporphyria with fatal liver failure.

Authors:  Y Nakahashi; H Miyazaki; Y Kadota; Y Naitoh; K Inoue; M Yamamoto; N Hayashi; S Taketani
Journal:  Hum Genet       Date:  1993-05       Impact factor: 4.132

View more
  3 in total

1.  Hepatic gene expression in protoporphyic Fech mice is associated with cholestatic injury but not a marked depletion of the heme regulatory pool.

Authors:  Reginald Davies; Arenda Schuurman; Colin R Barker; Bruce Clothier; Tatyana Chernova; Fiona M Higginson; David J Judah; David Dinsdale; Richard E Edwards; Peter Greaves; Timothy W Gant; Andrew G Smith
Journal:  Am J Pathol       Date:  2005-04       Impact factor: 4.307

2.  Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.

Authors:  Sharon S Cooperman; Esther G Meyron-Holtz; Hayden Olivierre-Wilson; Manik C Ghosh; Joseph P McConnell; Tracey A Rouault
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

3.  Experimental protoporphyria: effect of bile acids on liver damage induced by griseofulvin.

Authors:  María Del Carmen Martinez; Silvina Fernanda Ruspini; Susana Graciela Afonso; Roberto Meiss; Ana Maria Buzaleh; Alcira Batlle
Journal:  Biomed Res Int       Date:  2015-04-07       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.